Widening use of dexamethasone implant for the treatment of macular edema

Sustained-release intravitreal 0.7 mg dexamethasone (DEX) implant is approved in Europe for the treatment of macular edema related to diabetic retinopathy, branch retinal vein occlusion, central retinal vein occlusion, and non-infectious uveitis. The implant is formulated in a biodegradable copolyme...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Drug Des Devel Ther
Autores principales: Bonfiglio, Vincenza, Reibaldi, Michele, Fallico, Matteo, Russo, Andrea, Pizzo, Alessandra, Fichera, Stefano, Rapisarda, Carlo, Macchi, Iacopo, Avitabile, Teresio, Longo, Antonio
Formato: Artigo
Lenguaje:Inglês
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5566324/
https://ncbi.nlm.nih.gov/pubmed/28860707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S138922
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares